Related Experiment Video
Updated: Jul 7, 2026
Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging
Published on: September 12, 2025
Secreted enteric antimicrobial activity localises to the mucus surface layer
U Meyer-Hoffert1, M W Hornef, B Henriques-Normark
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Objectives:
The intestinal mucosa is constantly exposed to a dense and highly dynamic microbial flora and challenged by a variety of enteropathogenic bacteria. Antibacterial protection is provided in part by Paneth cell-derived antibacterial peptides such as the alpha-defensins. The mechanism of peptide-mediated antibacterial control and its functional importance for gut homeostasis has recently been appreciated in patients with Crohn's ileitis. In the present study, the spatial distribution of antimicrobial peptides was analysed within the small intestinal anatomical compartments such as the intestinal crypts, the overlaying mucus and the luminal content.
Methods:
Preparations from the different intestinal locations as well as whole mouse small intestine were extracted and separated by reversed-phase high-performance liquid chromatography. Antibacterial activity was determined in extracts, and the presence of antimicrobial peptides/proteins was confirmed by N-terminal sequencing, mass spectrometry analysis and immunodetection.
Results:
The secreted antibacterial activity was largely confined to the layer of mucus, whereas only minute amounts of activity were noted in the luminal content. The extractable activity originating from either crypt/mucus/lumen compartments respectively (given as a percentage) was for Listeria monocytogenes, 48 (4)/44 (4)/8 (8); Enterococcus faecalis, 44 (10)/49 (3)/7 (7); Bacterium megaterium, 56 (4)/42 (3)/2 (1); Streptococcus pyogenes, 48 (4)/46 (3)/6 (6); Escherichia coli, 46 (4)/47 (3)/7 (7); and Salmonella enterica sv. Typhimurium, 38 (3)/43 (7)/19 (10). A spectrum of antimicrobial peptides was identified in isolated mucus, which exhibited strong and contact-dependent antibacterial activity against both commensal and pathogenic bacteria.
Conclusion:
These findings show that secreted antimicrobial peptides are retained by the surface-overlaying mucus and thereby provide a combined physical and antibacterial barrier to prevent bacterial attachment and invasion. This distribution facilitates high local peptide concentration on vulnerable mucosal surfaces, while still allowing the presence of an enteric microbiota.
Insights
Antimicrobial peptides are retained in the mucus layer of the small intestine, forming a crucial barrier against bacterial invasion. This localization ensures high peptide concentrations at vulnerable mucosal surfaces while maintaining gut microbiota balance.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- The intestinal mucosa faces constant challenges from microbial flora and pathogens.
- Paneth cell-derived alpha-defensins are key antibacterial peptides for gut homeostasis.
- Understanding their distribution is crucial, especially in conditions like Crohn's ileitis.
Purpose of the Study:
- To analyze the spatial distribution of antimicrobial peptides within small intestinal compartments.
- To investigate the role of mucus in retaining these peptides.
- To understand their contribution to gut barrier function.
Main Methods:
- Extraction and separation of intestinal contents using reversed-phase high-performance liquid chromatography.
- Assay of antibacterial activity in various intestinal fractions.
- Confirmation of antimicrobial peptides via N-terminal sequencing, mass spectrometry, and immunodetection.
Main Results:
- Secreted antibacterial activity was primarily found in the mucus layer, with minimal amounts in luminal content.
- Antimicrobial peptides in mucus showed strong, contact-dependent activity against commensal and pathogenic bacteria.
- Specific activity percentages against various bacteria (e.g., Listeria monocytogenes, Escherichia coli) were quantified across crypt, mucus, and lumen compartments.
Conclusions:
- Secreted antimicrobial peptides are effectively retained within the mucus layer.
- This mucus-bound peptide layer acts as a physical and antibacterial barrier, preventing bacterial attachment and invasion.
- This localized concentration of peptides enhances mucosal defense without disrupting the enteric microbiota.
Related Concept Videos
01:18Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
01:25Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
01:05Physiology of Enteric Nervous System and Gut Health
01:25Regulation of the Digestive System
The effectors in this regulation system are glands and smooth muscles. Activation of these...
01:29Microbiota of the Respiratory Tract
01:26Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...